Xencor to Host First Quarter 2023 Financial Results Webcast and Conference Call on May 8, 2023

Author's Avatar
May 01, 2023

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced it will release first quarter 2023 financial results after the market closes on Monday, May 8, 2023.